Antibiotics: Technologies and Global Markets

Jan 2021| PHM025E| BCC Publishing
Report Overview

Report Highlights

The global market for antibiotics should grow from $44.4 billion in 2020 to reach $65.4 billion by 2025 at a compound annual growth rate (CAGR) of 8.1% during the period of 2020-2025.

Report Includes

  • 28 data tables and 16 additional tables
  • Comprehensive overview of the global market for antibiotics within the pharmaceutical industry
  • Analyses of the global market trends, with data corresponding to market size for 2018-2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Latest information on market growth drivers and opportunities, industry supply chain structure, regulatory developments, technological advancements, and demographic shifts shaping the overall antibiotics marketplace
  • Evaluation of market growth during the forecast period, and deep dive of market share analysis data basis of product type, product, route of administration, end-user and geographical region
  • Country specific data and analysis for the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa
  • Impact of COVID-19 on the pharmaceutical market for antibiotics and an outlook of short-term vs. long-term impacts of COVID-19 pandemic
  • Identification of the companies best positioned to meet the global market demand for antibiotic drugs on the basis of their proprietary technologies, M&A deals, collaborations, JVs and other strategic alliances
  • Detailed company profiles of the major global corporations, including Abbott, F. Hoffmann-La Roche AG, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer and Sanofi

Report Scope

The report focuses on newer drugs and innovations in chemical compounds, vaccines and biologicals, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control approaches, strategies and products; drugs used for symptomatic treatment and not for the elimination of the virus from the host; and details on manufacturers and suppliers of non-branded generics. This report will also highlight the current and future market potentiality of antibiotics with detailed analysis of competitive environment between the companies. Drivers, restraints, opportunities, pricing analysis, impact of COVID-19, other infectious diseases and a regulatory scenario assessment will be covered in the current report. The report covers a market projection for 2025, and a market share for key players.

The report segments the market for antibiotics based on product type, route of administration, application and geography. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA inhibitors and other inhibitors (RNA, Mycolic Acid, Folic Acid). Based on route of administration, the market is segmented into oral and topical. The market is also presented based on application type, which is further segmented into human and veterinary.

By geography, the market has been segmented into the North America, Europe, Asia-Pacific, South America, and Middle East and Africa regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2025.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Antibiotics: Technologies and Global Markets170 $5,500 Free
Chapter- 1: Introduction6Free DownloadFree
Chapter- 2: Summary and Highlights5$250Free
Chapter- 3: Market and Technology Background6$195Free
Chapter- 4: Market Dynamics13$423Free
Chapter- 5: Market Breakdown by Product19$618Free
Chapter- 6: Market Breakdown by Route of Administration11$358Free
Chapter- 7: Market Breakdown by Region60$1,953Free
Chapter- 8: Impact of COVID-19 on the Pharmaceutical Industry5$163Free
Chapter- 9: Clinical Developments and Pipeline Products4$130Free
Chapter- 10: Value Chain Analysis3$98Free
Chapter- 11: Regulatory Scenario5$163Free
Chapter- 12: Competitive Landscape4$130Free
Chapter- 13: Company Profiles28$911Free
Chapter- 14: Appendix: Acronyms1$33Free
Published - Mar-2016| Analyst - Neha Maliwal| Code - PHM025D

Report Highlights

The global systemic antibiotics market should reach nearly $44.7 billion in 2020 from nearly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020.

Report Includes

  • An overview of the global markets and related technologies for antibiotics.
  • Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
  • Breakdowns of the market by human application and veterinary application
  • A look at major market trends and the factors driving or inhibiting the growth of the global pharmaceutical antibiotics market and its various submarkets
  • Profiles of key players in the market and analysis of their core competencies and market shares
  • Detailed coverage of 
    • Beta–lactams.
      • Penicillin.
      • Cephalosporins.
      • Carbapenems.
    • Fluoroquinolones.
      • Second generation.
      • Third generation.
      • Others.
    • Macrolides.
    • Tetracycline.
    • Other antibiotic classes. 

Published - May-2014| Analyst - Neha Maliwal| Code - PHM025C

Report Highlights

The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%.

Report Includes

  • An overview of the global market for systemic antibiotics.
  • Analyses of global market trends, with data from 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Details on the factors most impacting the market, including major market growth inhibitors and catalysts.
  • Discussion on important trends and products.
  • Comprehensive profiles of leading companies in the industry.

Published - Nov-2009| Analyst - Syamala Ariyanchira| Code - PHM025B

Report Highlights

  • Overall sales in the current antibiotics and new products market were nearly $40 billion in 2008. It increased to $41.5 billion in 2009. By 2014, it is projected to increase to $65.5 billion, for a 5-year compound annual growth rate (CAGR) of 9.6%.
  • The largest segment antibiotic drugs market was nearly $36 billion in 2008; this further increased to $37 billion in 2009, this projected to reach $50 billion in 2014, for a 5-year CAGR of 5.9%.
  • Sales in the bacterial vaccines market amounted to $3.6 billion in 2008 which increased slightly to $3.9 billion in 2009. This is projected to increase to $15 billion in 2014, for a 5-year CAGR of 31.6%.
Published - Feb-2002| Analyst - Lynn Gray| Code - PHM025A

Report Highlights

  • Worldwide, the total market for new and currently available antibiotics reached $22.3 billion in 2001. Average annual growth rate (AAGR) of 9.1%, this market will climb to $34.5 billion in 2006.
  • Growth will be driven by new products, whose sales will rise at an AAGR of more than 50% to $7.4 billion in 2006, representing 21% of the total market.
  • Sales in 2001 were just under $1 billion, just 4% of the market.
  • In 2001, the market for currently available antibiotics was $21.3 billion and is projected to increase at an AAGR of only 4.9% to $27.2 billion by 2006.
  • From 2001 to 2006, some 40 new products or formulations could be introduced into the antibiotics sector.
  • Many of these drugs will likely prove effective against infectious disease organisms that have developed multidrug resistances, rejuvenating the antibiotics market.

Antibiotics: Technologies and Global Markets

Single User License: $5500

Member Price: FREE

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS